title: Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma.
authors.affiliation: a Department of Lymphoma & Myeloma , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
authors.forename: Hun Ju
authors.initials: HJ
authors.lastname: Lee
authors.affiliation: a Department of Lymphoma & Myeloma , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
authors.forename: Dai
authors.initials: D
authors.lastname: Chihara
authors.affiliation: a Department of Lymphoma & Myeloma , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
authors.affiliation: b Department of Cardiology , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
authors.forename: Elie
authors.initials: E
authors.lastname: Mouhayar
authors.affiliation: b Department of Cardiology , MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
authors.forename: Peter
authors.initials: P
authors.lastname: Kim
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D000369:Aged, 80 and over; D001281:Atrial Fibrillation / Q000139:chemically induced* / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine